Zonegran [zonisamide] in the treatment of binge eating disorder associated with obesity: A single center, double-blind, placebo-controlled, flexible-dose study in outpatients
Phase of Trial: Phase III
Latest Information Update: 21 Jun 2011
At a glance
- Drugs Zonisamide (Primary)
- Indications Binge-eating disorder
- Focus Therapeutic Use
- 21 Jun 2011 Actual initiation date (Aug 2005) added as reported by ClinicalTrials.gov.
- 21 Jun 2011 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 12 Mar 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov, last updated 12 Mar 2009